Skip to content
Get alerts
GovInfoNow
Unrated Drug recall · FDA · Published August 31, 2015

Oasis Medical Recalls ImproVue Eye Drops Due to pH Issues

Oasis Medical recalls 909 cartons of ImproVue Ophthalmic Lubricant Drops due to failed pH specifications. Check lot V0415F.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1418-2015DrugOasis Medical ›
Take action

Contact the company

Recalling firmOasis Medical, Inc.514 S Vermont Ave Bldg 510-528 · Glendora, CA 91741-6205
✎ GovInfoNow plain-language explainer

Oasis Medical, Inc. is recalling ImproVue Ophthalmic Lubricant Drops because the product failed to meet its pH specification. The recall covers 909 cartons distributed in Florida. The record does not specify any injuries or health effects resulting from this defect. Read more at govinfonow.com/recall/43781-oasis-medical-inc-recalls-improvue-ophthalmic-lubricant-drops-1-7.

Source Summary by GovInfoNow · govinfonow.com/recall/43781-oasis-medical-inc-recalls-improvue-ophthalmic-lubricant-drops-1-7 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1418-2015

Cite this page

“Oasis Medical Recalls ImproVue Eye Drops Due to pH Issues.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43781-oasis-medical-inc-recalls-improvue-ophthalmic-lubricant-drops-1-7. Based on FDA recall #D-1418-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1418-2015%22&limit=1).

The FDA announced on August 31, 2015, that Oasis Medical, Inc. is recalling ImproVue Ophthalmic Lubricant Drops due to a failed pH specification. The recall affects 909 cartons distributed in Florida.

How to tell if you have it

  • Brand: Oasis Medical
  • Product: ImproVue Ophthalmic Lubricant Drops (1.7% Hypromellose)
  • Size: 0.07 fl oz (2mL) Single Use Syringe
  • NDC: 62144-5510-05
  • Lot Code: V0415F
  • Expiration Date: 10/16
  • Distribution: Florida

The hazard

The product failed to meet pH specifications. The recall is classified as Class III.

Context

GovInfoNow's records show Oasis Medical, Inc. has issued four other recalls since May 14, 2014. Other recent recalls of similar products include the AbbVie PRED MILD Eye Drops recall (May 18, 2026) and the Sun Pharmaceutical Fluocinolone Acetonide Solution recall (December 30, 2025).

How to tell if you have this one

Look for ImproVue Ophthalmic Lubricant Drops (1.7% Hypromellose) in single-use syringes with an applicator tip. Check for NDC 62144-5510-05 and Lot # V0415F with an expiration date of 10/16.

  • Brand
    Oasis Medical
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed in Florida.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: yesFL

FDA distribution: “FL” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Florida.

Recall timeline

FDA terminated this recall 4 months after the firm started it.

1. Firm started the recall: Aug 31, 201512. FDA classified it Class III: Sep 9, 201523. Published in FDA’s Enforcement Report: Sep 16, 201534. FDA terminated the recall: Dec 18, 201542015
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Oasis Tears PF Eye Drops Recall: Lack of Sterility Assurance
Oasis MedicalAbbVie Recalls PRED MILD Eye Drops Due to Stability Issues
AbbVieAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.

Latest drug recalls

SUN PHARMACEUTICAL INDUSTRIES INC recalls Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro
Northstar Rx · September 25, 2026Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1418-2015 (August 31, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1418-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA